2:16-cr-00149
D. Me.Feb 28, 2022Background
- Defendant James Robertson, age 32, serving a 120-month federal sentence (≈30% served) at USP Coleman I; projected release Aug 28, 2027.
- Moved for compassionate release under 18 U.S.C. § 3582(c)(1)(A), citing kidney disease, essential hypertension, asthma, and other medical issues that he says increase COVID-19 risk.
- Robertson declined a Pfizer-BioNTech COVID-19 vaccine on May 6, 2021, citing concerns about interactions and efficacy.
- BOP data showed active and recovered COVID-19 cases at USP Coleman I and substantial vaccination among staff and inmates; no reported inmate COVID deaths at the facility.
- The Government urged that vaccine availability and Robertson’s refusal weigh against finding extraordinary and compelling reasons; the Court found his vaccine refusal significant and his medical concerns insufficient to justify release.
- The Court also denied relief on independent § 3553(a) grounds, citing Robertson’s recidivism (a second federal drug-trafficking offense while on supervised release), involvement with fentanyl, and violent history despite expressions of remorse.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Defendant’s medical conditions and COVID-19 risk constitute "extraordinary and compelling" reasons for release | Vaccine availability makes COVID risk insufficient for most prisoners | Medical conditions (kidney disease, hypertension, asthma, epilepsy) raise heightened risk of severe COVID | Denied: medical risk insufficient given vaccine availability and defendant’s unvaccinated status; refusal weighs heavily against finding extraordinary and compelling reasons |
| Effect of vaccine refusal on entitlement to compassionate release | Refusal undermines claim; courts should consider refusal as a negative factor | Refusal based on health concerns and doubts about efficacy | Denied: court treats refusal as significant; subjective concerns not supported by evidence; vaccination would mitigate risk |
| Whether § 3553(a) factors support a reduction (public safety/recidivism) | Granting release would endanger public given repeated drug trafficking, fentanyl involvement, and violent criminal history | Defendant cites remorse, renunciation of gangs, and rehabilitation goals | Denied: § 3553(a) factors independently weigh against release due to high recidivism risk and public-safety concerns |
| Applicability of Sentencing Commission policy statements | U.S.S.G. §1B1.13 governs BOP-initiated motions; not binding for prisoner-initiated motions but informative | Defendant may rely on broader circumstances in a prisoner-initiated motion | Court: §1B1.13 not binding but may serve as non-binding reference; court may consider broader circumstances in evaluating extraordinary and compelling reasons |
Key Cases Cited
- United States v. Saccoccia, 10 F.4th 1 (1st Cir.) (describing what constitutes extraordinary and compelling reasons and court’s evaluative role)
- United States v. Broadfield, 5 F.4th 801 (7th Cir.) (availability of vaccines generally prevents COVID risk from being extraordinary and compelling)
- United States v. Texeira-Nieves, 23 F.4th 48 (1st Cir.) (balance of § 3553(a) factors can independently justify denying compassionate release)
- Bivens v. Six Unknown Named Agents, 403 U.S. 388 (1971) (recognized as a potential civil remedy for constitutional violations by federal officers)